Users Coming Off Slimming Injections Regain Pounds Four Times Faster Compared to Dieters

Fresh analysis reveals that individuals who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise regimens.

Published data in a leading medical journal demonstrates that while overweight individuals can lose about a fifth of their total mass while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Users using such treatments must be informed of the risk of fast rebound weight gain when the medication ends," warns researcher Dr. Susan Jebb.

This pace of recovery means a reversion to original weight in about a year and a half.

Analyzing Therapies

The analysis, which looked at dozens of studies involving over 9,000 of patients, contrasted the results of these new drugs with older methods.

Researchers point out that individuals who lose weight through lifestyle changes alone generally see a slower weight regain—around 0.1 kg a month—post-intervention.

The Reason for the Quick Regain

Experts believe the mode of action of the injections explains the amplified weight return.

These medications imitate a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of GLP-1 levels far above than the body's typical production might result in the body to produce less of its own natural GLP-1, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this medication means hunger is uncontrolled, making excessive eating much more probable."

A Lifelong Issue?

The NHS recommend the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.

Many experts contend that, due to the likelihood of weight regain, the treatment might need to be ongoing.

This perspective is supported by drug manufacturers, who note that the findings "underscore the persistent character of obesity," akin to managing conditions like high blood pressure.

Patient Experiences

People who have discontinued the medication explain a intense return of appetite.

"It felt as if a trigger activating and you're instantly extremely hungry," recalled one woman.

The struggle is exacerbated if individuals have not established sustainable dietary or behavioural changes during treatment.

Widespread Use

Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with desire remaining high.

• Use is higher among females than men.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the medications through private healthcare rather than public health services.

In conclusion, researchers caution that while these medications are effective tools for shedding pounds, they are not a permanent fix and maintained weight loss likely depends on ongoing behavioural changes.